These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. [Multiple myeloma: analysis of prognostic factors and classification by stages]. Bladé J; Rozman C Sangre (Barc); 1984; 29(5):918-26. PubMed ID: 6523342 [No Abstract] [Full Text] [Related]
17. [Initial central nervous system involvement in a case of non-secretory multiple myeloma]. Calavia J; Loyola I; Richard C; Baro J; Recio M; Cuadrado MA; Zubizarreta A Sangre (Barc); 1993 Oct; 38(5):389-91. PubMed ID: 8140502 [TBL] [Abstract][Full Text] [Related]
18. [Drug-resistant multiple myeloma with high serum levels of lactate dehydrogenase and neutrophil infiltration in pleural effusion]. Kozawa M; Hata H; Kawaguchi T; Tsuji N; Mori S; Harada N; Nakahashi E; Sakata K; Matsuzaki H; Takatsuki K Rinsho Ketsueki; 1994 Jan; 35(1):49-53. PubMed ID: 8139102 [TBL] [Abstract][Full Text] [Related]
19. [Light chain myeloma: clinical study and prognostic factors ]. Redón J; Caballero M; Herranz C Med Clin (Barc); 1982 Jun 16-30; 79(2):54-8. PubMed ID: 6811809 [No Abstract] [Full Text] [Related]
20. [Prognostic factors and stages in multiple myeloma]. Hernández JM; San Miguel JF Sangre (Barc); 1984; 29(5):927-35. PubMed ID: 6523343 [No Abstract] [Full Text] [Related] [Next] [New Search]